Topical eye medications causing allergic contact dermatitis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Topical eye medications causing allergic contact dermatitis. / Ahlström, Malin Glindvad; Skov, Lone; Heegaard, Steffen; Zachariae, Claus; Garvey, Lene Heise; Johansen, Jeanne Duus.

I: Contact Dermatitis, Bind 88, Nr. 4, 2023, s. 294-299.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Ahlström, MG, Skov, L, Heegaard, S, Zachariae, C, Garvey, LH & Johansen, JD 2023, 'Topical eye medications causing allergic contact dermatitis', Contact Dermatitis, bind 88, nr. 4, s. 294-299. https://doi.org/10.1111/cod.14245

APA

Ahlström, M. G., Skov, L., Heegaard, S., Zachariae, C., Garvey, L. H., & Johansen, J. D. (2023). Topical eye medications causing allergic contact dermatitis. Contact Dermatitis, 88(4), 294-299. https://doi.org/10.1111/cod.14245

Vancouver

Ahlström MG, Skov L, Heegaard S, Zachariae C, Garvey LH, Johansen JD. Topical eye medications causing allergic contact dermatitis. Contact Dermatitis. 2023;88(4):294-299. https://doi.org/10.1111/cod.14245

Author

Ahlström, Malin Glindvad ; Skov, Lone ; Heegaard, Steffen ; Zachariae, Claus ; Garvey, Lene Heise ; Johansen, Jeanne Duus. / Topical eye medications causing allergic contact dermatitis. I: Contact Dermatitis. 2023 ; Bind 88, Nr. 4. s. 294-299.

Bibtex

@article{8e0349680bf54642a033ea76baf328ca,
title = "Topical eye medications causing allergic contact dermatitis",
abstract = "BACKGROUND: Allergic contact dermatitis (ACD) in the eye region caused by topical eye medications is difficult to diagnose and may be overlooked.OBJECTIVE: To study the characteristics and causative agents in patients with ACD caused by topical eye medications in a Danish tertiary dermatology department.METHODS: A retrospective study of 318 patients, patch tested between 2013 and 2021 due to suspected ACD to topical eye medications. All patients were tested with a locally developed eye medication series, some were additionally tested with suspected eye medications. Medical records were studied in patch test positive patients.RESULTS: Contact allergy to a topical eye allergen/medication was found in 12.9% (n = 41) of 318 patients, and culprit allergens were phenylephrine (6.9%), timolol (2.5%) and ketotifen (1.6%). Patch test positive patients were often previously diagnosed with cataract (29.3%) or glaucoma (24.4%), and the majority reported more than one previous reaction. Initial symptoms were oedema (56.0%), erythema (48.8%) and dermatitis (31.7%) in the eye region, and facial dermatitis was also seen.CONCLUSIONS: Patients with symptoms from the eye region who have been using topical eye medications should be patch tested with ingredients from commonly used eye medications supplemented by the products tested 'as is'.",
author = "Ahlstr{\"o}m, {Malin Glindvad} and Lone Skov and Steffen Heegaard and Claus Zachariae and Garvey, {Lene Heise} and Johansen, {Jeanne Duus}",
note = "{\textcopyright} 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.",
year = "2023",
doi = "10.1111/cod.14245",
language = "English",
volume = "88",
pages = "294--299",
journal = "Contact Dermatitis",
issn = "0105-1873",
publisher = "Wiley-Blackwell",
number = "4",

}

RIS

TY - JOUR

T1 - Topical eye medications causing allergic contact dermatitis

AU - Ahlström, Malin Glindvad

AU - Skov, Lone

AU - Heegaard, Steffen

AU - Zachariae, Claus

AU - Garvey, Lene Heise

AU - Johansen, Jeanne Duus

N1 - © 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

PY - 2023

Y1 - 2023

N2 - BACKGROUND: Allergic contact dermatitis (ACD) in the eye region caused by topical eye medications is difficult to diagnose and may be overlooked.OBJECTIVE: To study the characteristics and causative agents in patients with ACD caused by topical eye medications in a Danish tertiary dermatology department.METHODS: A retrospective study of 318 patients, patch tested between 2013 and 2021 due to suspected ACD to topical eye medications. All patients were tested with a locally developed eye medication series, some were additionally tested with suspected eye medications. Medical records were studied in patch test positive patients.RESULTS: Contact allergy to a topical eye allergen/medication was found in 12.9% (n = 41) of 318 patients, and culprit allergens were phenylephrine (6.9%), timolol (2.5%) and ketotifen (1.6%). Patch test positive patients were often previously diagnosed with cataract (29.3%) or glaucoma (24.4%), and the majority reported more than one previous reaction. Initial symptoms were oedema (56.0%), erythema (48.8%) and dermatitis (31.7%) in the eye region, and facial dermatitis was also seen.CONCLUSIONS: Patients with symptoms from the eye region who have been using topical eye medications should be patch tested with ingredients from commonly used eye medications supplemented by the products tested 'as is'.

AB - BACKGROUND: Allergic contact dermatitis (ACD) in the eye region caused by topical eye medications is difficult to diagnose and may be overlooked.OBJECTIVE: To study the characteristics and causative agents in patients with ACD caused by topical eye medications in a Danish tertiary dermatology department.METHODS: A retrospective study of 318 patients, patch tested between 2013 and 2021 due to suspected ACD to topical eye medications. All patients were tested with a locally developed eye medication series, some were additionally tested with suspected eye medications. Medical records were studied in patch test positive patients.RESULTS: Contact allergy to a topical eye allergen/medication was found in 12.9% (n = 41) of 318 patients, and culprit allergens were phenylephrine (6.9%), timolol (2.5%) and ketotifen (1.6%). Patch test positive patients were often previously diagnosed with cataract (29.3%) or glaucoma (24.4%), and the majority reported more than one previous reaction. Initial symptoms were oedema (56.0%), erythema (48.8%) and dermatitis (31.7%) in the eye region, and facial dermatitis was also seen.CONCLUSIONS: Patients with symptoms from the eye region who have been using topical eye medications should be patch tested with ingredients from commonly used eye medications supplemented by the products tested 'as is'.

U2 - 10.1111/cod.14245

DO - 10.1111/cod.14245

M3 - Journal article

C2 - 36382619

VL - 88

SP - 294

EP - 299

JO - Contact Dermatitis

JF - Contact Dermatitis

SN - 0105-1873

IS - 4

ER -

ID: 334011217